BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35554754)

  • 1. Usefulness of dual isotope
    Osawa S; Tosaka M; Horiguchi K; Tokue A; Higuchi T; Tsushima Y; Yoshimoto Y
    Int J Clin Oncol; 2022 Aug; 27(8):1264-1272. PubMed ID: 35554754
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
    Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High 123I-IMP retention on SPECT image in primary central nervous system lymphoma.
    Shinoda J; Yano H; Murase S; Yoshimura S; Sakai N; Asano T
    J Neurooncol; 2003 Feb; 61(3):261-5. PubMed ID: 12675320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.
    Yu X; Hong W; Ye M; Lai M; Shi C; Li L; Ye K; Xu J; Ai R; Shan C; Cai L; Luo L
    Eur Radiol; 2023 Aug; 33(8):5357-5367. PubMed ID: 37171492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
    Choi YS; Lee HJ; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
    Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
    Inoue A; Matsumoto S; Ohnishi T; Miyazaki Y; Kinnami S; Kanno K; Honda T; Kurata M; Taniwaki M; Kusakabe K; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Kunieda T
    World Neurosurg; 2023 Apr; 172():e517-e523. PubMed ID: 36690204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of 123I-IMP SPECT in non-Hodgkin's lymphoma of the central nervous system.
    Akiyama Y; Moritake K; Yamasaki T; Kimura Y; Kaneko A; Yamamoto Y; Miyazaki T; Daisu M
    J Nucl Med; 2000 Nov; 41(11):1777-83. PubMed ID: 11079483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
    Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Kitamura Y; Mizoguchi M; Yoshimoto K; Kuga D; Suzuki SO; Baba S; Isoda T; Iwaki T; Iihara K; Honda H
    J Magn Reson Imaging; 2016 Nov; 44(5):1256-1261. PubMed ID: 27093558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
    Wang P; Shi YH; Li JY; Zhang CZ
    World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of brain tumors by simultaneous dual isotope SPECT with 201Tl-chloride and 99mTc-MIBI].
    Nagai H; Yamasaki T; Yamamoto Y; Takada D; Miyazaki T; Sugimoto K; Matsumoto Y; Akiyama Y; Moritake K
    No Shinkei Geka; 2004 Oct; 32(10):1029-37. PubMed ID: 15529789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
    Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    You SH; Yun TJ; Choi HJ; Yoo RE; Kang KM; Choi SH; Kim JH; Sohn CH
    Eur Radiol; 2018 Sep; 28(9):3801-3810. PubMed ID: 29619520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 123I-IMP SPET in the diagnosis of primary central nervous system lymphoma.
    Yoshikai T; Fukahori T; Ishimaru J; Kato A; Uchino A; Tabuchi K; Kudo S
    Eur J Nucl Med; 2001 Jan; 28(1):25-32. PubMed ID: 11202448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
    Kawai N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
    No Shinkei Geka; 2013 Feb; 41(2):117-26. PubMed ID: 23378387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining
    Hatakeyama J; Ono T; Takahashi M; Oda M; Shimizu H
    Neurol Med Chir (Tokyo); 2021 Jun; 61(6):367-375. PubMed ID: 33967177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.
    Bao S; Watanabe Y; Takahashi H; Tanaka H; Arisawa A; Matsuo C; Wu R; Fujimoto Y; Tomiyama N
    Magn Reson Med Sci; 2019 Jan; 18(1):53-61. PubMed ID: 29848919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy.
    Schwartz RB; Holman BL; Polak JF; Garada BM; Schwartz MS; Folkerth R; Carvalho PA; Loeffler JS; Shrieve DC; Black PM; Alexander E
    J Neurosurg; 1998 Jul; 89(1):60-8. PubMed ID: 9647173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
    Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
    Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating glioblastoma from primary central nervous system lymphoma of atypical manifestation using multiparametric magnetic resonance imaging: A comparative study.
    Feng A; Li L; Huang T; Li S; He N; Huang L; Zeng M; Lyu J
    Heliyon; 2023 Apr; 9(4):e15150. PubMed ID: 37095995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balanced transformer: efficient classification of glioblastoma and primary central nervous system lymphoma.
    Wang S; Wu J; Chen M; Huang S; Huang Q
    Phys Med Biol; 2024 Feb; 69(4):. PubMed ID: 38232389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.